UTSW Radiation Oncology shared a post on LinkedIn:
“Now enrolling: the MORPHEUS-Rectal clinical trial at UT Southwestern, Dallas. This phase three study compares two radiation dose-escalation strategies to raise complete-response rates and help patients preserve the organ and avoid surgery for Rectal Cancer. PI: Dr. Aurelie Garant
Eligibility and contact info.”
Other articles about UT Southwestern Radiation Oncology on OncoDaily.